HAE
Haemonetics·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HAE fundamentals
Haemonetics (HAE) released its earnings on Nov 6, 2025: revenue was 327.00M (YoY -5.49%), beat estimates; EPS was 1.27 (YoY +13.39%), beat estimates.
Revenue / YoY
327.00M
-5.49%
EPS / YoY
1.27
+13.39%
Report date
Nov 6, 2025
HAE Earnings Call Summary for Q2,2026
- Revenue Growth: Q2 organic +9% ex CSL, full year guidance raised to +7% to +10% organic. Adjusted EPS guidance $4.80-$5.00.
- Plasma Strength: Organic +19% Q2, U.S. collections +high single digits. Full year organic ex CSL +14% to +17%.
- Blood Management Excellence: +12% Q2, HN cartridge adoption and TEG innovation driving margins.
- Vascular Closure Turnaround: Field force realignment, MVP/XL growth, and Vivasure acquisition nearing completion.
- Cash Generation: Free cash flow $89M Q2, full year guidance $170M-$210M. Share buybacks $75M year-to-date.
EPS
Revenue
Revenue & Expenses
HAE has released its 2026 Q2 earnings report, with revenue of 327.31M, reflecting a YoY change of -5.27%, and net profit of 38.68M, showing a YoY change of 14.34%. The Sankey diagram below clearly presents HAE's revenue sources and cost distribution.
Key Indicators
Haemonetics (HAE) key financial stats and ratios, covering profitability, financial health, and leverage.
Haemonetics (HAE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Haemonetics (HAE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Haemonetics (HAE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Haemonetics (HAE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Haemonetics (HAE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Haemonetics’s earnings call?What were the key takeaways from Haemonetics's earnings call?What is the market's earnings forecast for Haemonetics next quarter?Did Haemonetics beat or miss consensus estimates last quarter?What does Haemonetics do and what are its main business segments?What is Haemonetics's latest dividend and current dividend yield?What guidance did Haemonetics's management provide for the next earnings period?What is Haemonetics's gross profit margin?
